These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9859098)

  • 1. [Protease inhibitor-associated hypertriglyceridemia and diabetes mellitus in HIV-infected patients].
    Knobel H; Goday A; Grau S
    Med Clin (Barc); 1998 Nov; 111(15):599. PubMed ID: 9859098
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperlipidaemia following treatment with protease inhibitors in patients with HIV-1 infection.
    Churchill DR; Pym AS; Babiker AG; Back DJ; Weber JN
    Br J Clin Pharmacol; 1998 Nov; 46(5):518-9. PubMed ID: 9833608
    [No Abstract]   [Full Text] [Related]  

  • 3. AIDS and endocrinology.
    Laurence J
    AIDS Patient Care STDS; 1997 Oct; 11(5):317-8. PubMed ID: 11361811
    [No Abstract]   [Full Text] [Related]  

  • 4. [Metabolic anomalies after antiretroviral treatment].
    Basdevant A
    Journ Annu Diabetol Hotel Dieu; 2000; ():167-77. PubMed ID: 10932879
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term cardiovascular risk with protease inhibitors and management of the dyslipidemia.
    Kannel WB; Giordano M
    Am J Cardiol; 2004 Oct; 94(7):901-6. PubMed ID: 15464673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic effects of protease inhibitor therapy.
    Bernasconi E
    AIDS Read; 1999 Jul; 9(4):254-6, 259-60, 266-9. PubMed ID: 12737115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metabolic complications associated with use of protease inhibitors].
    Mosnier-Pudar H
    Ann Med Interne (Paris); 2000 Jun; 151(4):278-82. PubMed ID: 10922955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study.
    Brown TT; Cole SR; Li X; Kingsley LA; Palella FJ; Riddler SA; Visscher BR; Margolick JB; Dobs AS
    Arch Intern Med; 2005 May; 165(10):1179-84. PubMed ID: 15911733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frozen shoulder: a new delayed complication of protease inhibitor therapy?
    Zabraniecki L; Doub A; Mularczyk M; Andrieu V; Marc V; Ginesty E; Dromer C; Massip P; Fournié B
    Rev Rhum Engl Ed; 1998 Jan; 65(1):72-4. PubMed ID: 9523391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 protease inhibitor-associated partial lipodystrophy: clinicopathologic review of 14 cases.
    Pujol RM; Domingo P; Xavier-Matias-Guiu ; Francia E; Sanbeat MA; Alomar A; Vazquez G
    J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):193-8. PubMed ID: 10642672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diabetes mellitus in primary hypertriglyceridemia with contraindicated insulin therapy].
    Braunsteiner H; Herbst M; Sailer S; Sandhofer F
    Wien Klin Wochenschr; 1968 May; 80(21):415-7. PubMed ID: 5704568
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of diabetes mellitus and dyslipidemia among antiretroviral naive patients co-infected with hepatitis C virus (HCV) and HIV-1 compared to patients without co-infection.
    Visnegarwala F; Chen L; Raghavan S; Tedaldi E
    J Infect; 2005 May; 50(4):331-7. PubMed ID: 15845431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesive capsulitis of shoulder and treatment with protease inhibitors in patients with human immunodeficiency virus infection: report of 8 cases.
    Grasland A; Ziza JM; Raguin G; Pouchot J; Vinceneux P
    J Rheumatol; 2000 Nov; 27(11):2642-6. PubMed ID: 11093447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral protease inhibitor therapy leads to hyperglycaemia, hyperlipidaemia and lipodystrophy.
    Sangraula H; Sharma KK; Dwivedi S
    Natl Med J India; 2001; 14(6):347-8. PubMed ID: 11804366
    [No Abstract]   [Full Text] [Related]  

  • 15. Diabetes mellitus associated with protease inhibitor use.
    Rodríguez-Rosado R; Soriano V; Blanco F; Dona C; González-Lahoz J
    Eur J Clin Microbiol Infect Dis; 1999 Sep; 18(9):675-7. PubMed ID: 10534196
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipid evaluation in HIV-1-positive patients treated with protease inhibitors.
    Schmidt HH; Behrens G; Genschel J; Stoll M; Dejam A; Haas R; Manns MP; Schmidt RE
    Antivir Ther; 1999; 4(3):163-70. PubMed ID: 12731756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse metabolic consequences of HIV protease inhibitor therapy: the search for a central mechanism.
    Hruz PW; Murata H; Mueckler M
    Am J Physiol Endocrinol Metab; 2001 Apr; 280(4):E549-53. PubMed ID: 11254460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Osteonecrosis in HIV-infected patients].
    Bottaro EG; Figueroa RH; Scapellato PG; Vidal GI; Rodriguez Brieschke MT; Da Representaçao S; Seoane MB; Laurido MF; Caiafa D; Lopardo G; Herrera F; Cassetti I
    Medicina (B Aires); 2004; 64(4):325-31. PubMed ID: 15338975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003.
    Martí C; Peña JM; Bates I; Madero R; de José I; Pallardo LF; Arribas JR; Gonzalez-Garcia J; Gonzalez A; Vazquez JJ
    Acta Obstet Gynecol Scand; 2007; 86(4):409-15. PubMed ID: 17486461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensory neuropathy in human immunodeficiency virus/acquired immunodeficiency syndrome patients: protease inhibitor-mediated neurotoxicity.
    Pettersen JA; Jones G; Worthington C; Krentz HB; Keppler OT; Hoke A; Gill MJ; Power C
    Ann Neurol; 2006 May; 59(5):816-24. PubMed ID: 16634006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.